KSKsenia K. Soldatova

Ksenia K. Soldatova

*This is an algorithmically generated author record based on publicly available information.

Ksenia K. Soldatova has a total of 82 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Idiopathic pulmonary hemosiderosis in children: results of a multicenter study

    by Oleg G. Malyshev, Малышев Олег Геннадьевич, Shamil' A. Gitinov, Гитинов Шамиль Абдулвахидович, Tatiana A. Krashilina, Крашилина Татьяна Александровна, Elina A. Nafanailova, Нафанаилова Элина Александровна, Ksenia K. Soldatova, Солдатова Ксения Константиновна, et al.

    Background. Idiopathic pulmonary hemosiderosis (IPH) is a rare interstitial lung disease associated with recurrent diffuse alveolar hemorrhage, anemia, and the risk of pulmonary fibrosis. Aim. To describe the clinical and laboratory, computed tomographic, diagnostic, therapeutic characteristics and outcomes of children with IPH. Materials and methods. This ambispective descriptive multicenter study included 11 patients with disease onset before 18 years of age and pulmonary hemorrhage/hemosiderosis documented by bronchoscopy with bronchoalveolar lavage, cytological and/or morphological examination, after exclusion of alternative causes. Clinical history, laboratory and instrumental findings, treatment, and outcomes were evaluated. Results. The cohort included 5 boys and 6 girls. The median age at IPH onset was 6.0 [3.7; 8.6] years, the median age at diagnosis was 8.0 [4.9; 9.7] years, the median diagnostic delay was 4.9 [1.8; 22.8] months, and the median minimum hemoglobin level was 52 [38.5; 98.5] g/L (data available for 10 patients). Anemia was documented in all patients, and hemoptysis in 6/11 (55%). Signs of diffuse lung involvement on chest CT were present in all patients; ground-glass opacities and consolidation were the most common findings. Six patients required ICU care, 3 required mechanical ventilation, and 8 received red blood cell transfusions. All patients received systemic glucocorticoids; azathioprine was used in 5, rituximab in 4, and cyclophosphamide in 1 patient. Three patients died. Conclusion. IPH debuts anemia in children. The absence of hemoptysis does not exclude diffuse alveolar hemorrhage. Early computed tomography of the chest organs, bronchoscopy with bronchoalveolar lavage, the search for siderophages and the exclusion of secondary causes are the key stages of diagnosis. In severe and recurrent cases, multidisciplinary management and steroid-sparing immunosuppressive therapy are required.

  • PULMONARY EPITHELIOID HEMANGIOENDOTHELIOMA IN AN ADOLESCENT: A CLINICAL CASE

    by Yu.V. Chernenkov, O.I. Gumeniuk, E.V. Balashova, I.V. Goremykin, I.S. Davydov, E.V. Deeva, M.S. Kubirov, G.N. Maslyakova, A.E. Paltseva, E.R. Rogacheva, et al.

    Pulmonary epithelioid hemangioendothelioma (PEH) is a rare vascular neoplasm of intermediate malignancy characterized by a highly variable clinical course and significant diagnostic challenges. In pediatric practice, the incidence of this condition is extremely low, which often leads to diagnostic errors, particularly in cases with atypical molecular variants. Objective: To demonstrate the clinical, instrumental, and morphological features of pulmonary epithelioid hemangioendothelioma in children and to highlight the challenges of differential diagnosis. Materials and Methods: We present a clinical case of a 14-year-old adolescent with bilateral diffuse lung involvement who underwent a comprehensive diagnostic evaluation, including chest computed tomography, bronchoscopy with biopsy, histological and immunohistochemical analysis, as well as lung function testing. Results: Multiple bilateral pulmonary nodules were identified, while no significant functional impairment was observed. The initial histological findings were consistent with organizing pneumonia. The differential diagnosis included tuberculosis, sarcoidosis, pulmonary alveolar proteinosis, and IgG4-related lung disease. The final diagnosis was established after expert histopathological review, revealing features of PEH with positive expression of endothelial markers (CD31, CD34, ERG) and absence of CAMTA1 and TFE3 expression. This pattern does not correspond to the typical molecular variants observed in the majority of cases and underscores the molecular heterogeneity of the tumor. Conclusion: This case demonstrates that PEH may mimic inflammatory lung diseases and be associated with negative results for key molecular markers (CAMTA1, TFE3). Accurate diagnosis requires a comprehensive approach, including detailed histological and immunohistochemical evaluation. Awareness of this entity in the differential diagnosis of diffuse lung diseases in children may reduce the risk of diagnostic errors and highlights the importance of a multidisciplinary approach involving pediatricians, pulmonologists, oncologists, and pathologists.

  • Open Access

    Clinical case of hypertrophic pyloric stenosis in a newborn with cow’s milk allergy

    by A.L. Karavaeva, L.A. Timofeeva, K.K. Soldatova, N.A. Pekareva, A.V. Degtyareva, E.I. Dorofeeva, Yu.L. Podurovskaya, E.A. Filippova, Yu.K. Bykova, A.B. Sugak, et al.

    Случай врожденного гипертрофического пилоростеноза у ребенка с аллергией к белкам коровьего молока